Clinical Trial Update: Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Virus Specific Cytotoxic T-Lymphocytes to treat refractory cytomegalovirus infections in individuals with primary immunodefici…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection
• Immunodeficiency

Drugs mentioned

• Virus Specific Cytotoxic T-Lymphocytes (CTLs)

Snippet

Sponsor: New York Medical College | Conditions: Cytomegalovirus Infections, Primary Immune Deficiency Disorder | Phase 2 | Status: RECRUITING